Specify a stock or a cryptocurrency in the search bar to get a summary
Beijing Kawin Technology Share-holding Co Ltd
688687Beijing Kawin Technology Share-Holding Co., Ltd. engages in the development and production of pharmaceutical products primarily in the areas of liver diseases in China. The company's products include recombinant human interferon alfa-2b injection; vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; and compound glycyrrhizin. It has strategic partnership with Legend Capital, Haitong Capital, and Cybernaut. The company was founded in 2008 and is based in Beijing, China. Address: Building 3, No. 6, Rongjing East Street, Beijing, China, 100176
Analytics
WallStreet Target Price
273.37 CNYP/E ratio
34.9012Dividend Yield
0.91 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688687
Dividend Analytics 688687
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
34 %Dividend History 688687
Stock Valuation 688687
Financials 688687
Results | 2019 | Dynamics |